Global cohort analysis demonstrates that moderate glycemic control improves cardiovascular outcomes in diabetic kidney transplant recipients, suggesting benefits for personalized treatment.
In this global retrospective observational study, moderate glycemic control (HbA1c ~ 7 - 8% measured 1 - 2 years post transplant) was associated with lower cardiovascular events and mortality in type 2 diabetic KTRs. These findings support individualized targets aimed at avoiding both poor control and overly intensive lowering.
No takes yet. Share an insight, caveat, or question.
Bobba et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: